Zdrowie i gospodarka · 12/05/2021
FDA Publishes Draft Guidance for Elemental Impurities in Pharmaceuticals
The FDA has released a draft guidance for industry on elemental impurities in pharmaceuticals, developed under the ICH, which provides permissible daily exposures and risk assessment considerations for various routes of administration.
Source: Federal Register — Food and Drug AdministrationOpen original release →